AstraZeneca’s COVID Jab Vaxzevria Gets EU Approval as Booster
AstraZeneca’s COVID jab has been approved in the EU as a booster or third jab, the British pharma giant confirmed on Monday. The European Medicines...
Category : HEALTHCARE
Dr Reddy’s Lowers Price of Sputnik Booster
Dr Reddy’s lab said on May 19 that it would reduce the price of the Sputnik Light vaccine, which will be used as a booster...
Second Dose of Covid Booster for Most Vulnerable Could Bring Benefits, WHO Says
As omicron and its sub-variants continue to spread globally, there may be some benefit to delivering a second dose of a coronavirus booster vaccine to...
Takeda Pharmaceutical Co Launches Haemophilia Drug Adynovate
Takeda Pharmaceuticals Co Ltd on Monday announced the expansion of its rare disease portfolio in India with the launch of Adynovate for the treatment of...
Alembic Pharma Unit Receives Final USFDA Approval for Generic Version of Fever Blisters
Alembic Pharmaceuticals said Wednesday that its wholly-owned subsidiary, Aleor Dermaceuticals, has received final approval from US health regulators for its generic Docosanol cream to treat...
Pharma CEOs Urge Centre to Rationalise Prices of Essential Medicines
Industry representatives from pharmaceutical companies are urging the Centre to rationalise the pricing of various medicines on the National List of Essential Medicines (NLEM), given...
Serum Halts Production Of 200 million Doses of COVID-19 Vaccine
Serum Institute of India Ltd, the world’s largest vaccine maker and a significant supplier of Covid-19 vaccines to developing countries, has raised its stockpile to...
Metropolis Healthcare Plans to Open 1,800 Collection Centres in 3 years
Diagnostic chain Metropolis Healthcare was all set to open 1,800 new collection centres and 90 processing labs across the country in the next three years,...
Glenmark to Conduct Phase 1 Trials of Its Molecule on Cancer Patients
Glenmark Pharma said it had received approval from the Drug Controller General of India (DCGI) to conduct phase 1 clinical trials of its molecule, GRC...
Cadila Pharma Launches First 3-Dose Vaccine Against Rabies
Cadila Pharmaceuticals announced that it had developed its first novel three-dose vaccine against rabies. The three-dose vaccine called ‘ThRabis’ is a recombinant nano-particle based G...